Key points are not available for this paper at this time.
Rituximab was both effective and safe in HIV-infected patients with chemotherapy-dependent MCD.
Gérard et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: